IN DATA

Powered by 

INSIDE THE DEAL

AstraZeneca and Fusion team up on targeted alpha therapies

Fusion and AstraZeneca are partnering to develop next-generation cancer treatments

Deals Analysis

North America deals volume up 4% YoY

North America is leading in terms of deal value, but recorded the lowest YoY growth in deals volume at 4%

Rankings

Who's leading Japan's R&D expenditure?

Our pharma industry key list brings you the 15 leading companies in Japan by R&D expenditure